Cardiotonic agents. 2. (Imidazolyl)aroylimidazolones, highly potent and selective positive inotropic agents

Authors:
  • AHAlfred A. Hagedorn
    Alfred A. Hagedorn
  • PEPaul W. Erhardt
    Paul W. Erhardt
  • WLWilliam C. Lumma
    William C. Lumma
  • RWRonald A. Wohl
    Ronald A. Wohl
  • ECElinor Cantor
    Elinor Cantor
  • YCYuo Ling Chou
    Yuo Ling Chou
  • WIWilliam R. Ingebretsen
    William R. Ingebretsen
  • JLJohn W. Lampe
    John W. Lampe
  • DPDavid Pang
    David Pang

Abstract
A series of 4-alkyl-1,3-dihydro-5-[(1H-imidazolyl)benzoyl]-2H-imidazol-2-ones 9 was synthesized and evaluated in vitro for positive inotropic and cyclic AMP phosphodiesterase inhibitory activity. A wide range of inotropic and enzyme-inhibitory potencies was observed, substitution on the imidazolyl moiety being the major determinant of activity. The 4-ethyl-5-[4-(1H-imidazol-1-yl)benzoyl] congener 9g exhibited the highest potency in vitro. Incorporation of a methyl group at the imidazolyl 2-position gave 9h, which was less potent but remarkably selective in vivo for positive inotropic effects over heart rate and hypotensive effects.